News for Merck Co.

Markets Insider Automation 13h

Merck&Co hosts conference call for investors

Seeking Alpha 3d

Merck Keytruda, anti-TIGIT therapy coformulation hits setback in mid-stage trial

Benzinga 3d

Here's How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years

TipRanks 3d

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Quest Diagnostics (DGX) and Fusion Pharmaceuticals (FUSN)

Seeking Alpha 3d

Medicare publishes initial guidance on drug price negotiations

Seeking Alpha 4d

Organon draws bullish views at Raymond James on Humira biosimilar launch

Zacks 4d

Merck (MRK) Gains As Market Dips: What You Should Know

Seeking Alpha 5d

AbbVie, Gilead, Seagen among firms fined for raising prices faster than inflation

TipRanks 5d

Mizuho Securities Reaffirms Their Buy Rating on Merck & Company (MRK)

Zacks 6d

Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock

Seeking Alpha 6d

Pfizer CEO doesn't see antitrust as stumbling block for Seagen acquisition

Seeking Alpha 6d

Merck asks EMA to reconsider recommendation to reject authorizing COVID pill molnupiravir

Benzinga 6d

Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023

Seeking Alpha 7d

Moderna gains as Cowen upgrades citing a favorable catalyst path

Seeking Alpha 7d

Merck downgraded at Wells Fargo on valuation

Benzinga 7d

Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows

Seeking Alpha 7d

Pfizer to acquire cancer drugmaker Seagen for $43B

Benzinga 9d

A Look Into Merck & Co's Debt

Benzinga 10d

Expert Ratings for Merck & Co

Benzinga 10d

Expert Ratings for Merck & Co

Benzinga 10d

United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday

RTTNews 10d

Merck: Phase 2/3 CCTG IND.227/KEYNOTE-483 Trial With KEYTRUDA Meets Primary Endpoint

Seeking Alpha 10d

Merck’s Keytruda succeeds in pleural mesothelioma study with chemotherapy

Zacks 10d

Merck (MRK) Stock Moves -0.63%: What You Should Know

Seeking Alpha 10d

Biden budget to save $160B by allowing Medicare to negotiate prices for more drugs

Benzinga 10d

Peering Into Merck & Co's Recent Short Interest

TipRanks 11d

SVB Securities Sticks to Their Buy Rating for Merck & Company (MRK)

Seeking Alpha 11d

Why did OPKO Health stock jump today? Vaccine license deal with Merck

InvestorPlace 11d

Dividend Stocks Alert: 10 Top Holdings From the SCHD ETF

Benzinga 11d

OPKO Health's Cancer & Infectious Disease Focused Subsidiary Inks Vaccine Development Pact With Merck

Benzinga 11d

OPKO Health's Cancer & Infectious Disease Focused Subsidiary Inks Vaccine Development Pact With Merck

Zacks 12d

Merck (MRK) Reports Detailed Data From PAH Study on Sotatercept

Seeking Alpha 12d

Opko stock surges ~25% on license deal with Merck for potential EBV vaccine

Seeking Alpha 12d

Sleep-at-night stocks for those hedging or risk averse

Benzinga 12d

Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason

Benzinga 12d

Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success

Seeking Alpha 12d

Gossamer downgraded at Raymond James after Merck data for PAH candidate

Benzinga 13d

DocuSign To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday

Seeking Alpha 13d

Biden to announce plan to keep Medicare solvent beyond 2050

TipRanks 13d

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Stoke Therapeutics (STOK) and Day One Biopharmaceuticals (DAWN)

TipRanks 13d

Merck & Company (MRK) Receives a Buy from Bank of America Securities

TipRanks 13d

Wall Street Analysts Are Neutral on Top Healthcare Picks

Seeking Alpha 13d

Merck posts full Phase 3 data for sotatercept in pulmonary arterial hypertension

TipRanks 13d

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Adaptimmune Therapeutics (ADAP)

Seeking Alpha 13d

Moderna hopes for FDA accelerated approval of cancer vaccine

Benzinga 13d

Merck Highlights Promising Data From Two Candidates In Heart Diseases

Seeking Alpha 13d

Seagen seesaws amid report that Pfizer only bidder for the cancer-focused biotech

TipRanks 13d

Mizuho Securities Sticks to Their Buy Rating for Merck & Company (MRK)

Seeking Alpha 13d

Merck to start phase 3 of oral PCSK9 inhibitor for cholesterol following mid-stage results

Seeking Alpha 13d

Merck, initiated at buy, is Jefferies top pharma pick

Merck Peer Group News

12/11/20	Pfizer falls 2% as FDA nears final authorization of its COVID-19 vaccine
12/01/20	S&P 500 and Nasdaq close at record highs as investors bet that a vaccine will drive an economic rebound
11/18/20	Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval
11/09/20	Gold slides the most in 3 months as encouraging vaccine data boosts risk appetites
09/21/20	Healthcare stocks plunge amid broad market rout as Ruth Bader Ginsburg's death creates uncertainty around Obamacare
08/19/20	Momenta Pharmaceuticals spikes 69% after agreeing to $6.5 billion Johnson & Johnson takeover
07/13/20	Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines 'fast track' status (PFE, BNTX)
07/01/20	Pfizer leaps 6% after releasing positive trial results for coronavirus vaccine